Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2022-07-01 00:00:00 ET · period of report 2022-05-31 · accession 0001209191-22-040113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-01 | 2022-05-31 | CPIX | Pavliv Leo | SVP, Chief Development Off | J - Other | $2.09 | -33.5K | 129.6K | -21% | -$70.0K |
| DM | 2022-07-01 | 2021-03-17+ | CPIX | Pavliv Leo | SVP, Chief Development Off | D - Sale to Iss | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | J | D | 33,500 | $2.09 | 129,618 | D | — | — | |
| 2 | Derivative | Options (right to buy) | 2021-03-17 | D | D | 5,000 | $0.00 | 0 | D | $3.22 · 2025-03-17 to 2031-03-17 | 5,000 Common Stock | (F1) Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022. All unvested equity awards forfeited upon retirement. |
| 3 | Derivative | Options (right to buy) | 2022-03-16 | D | D | 5,000 | $0.00 | 0 | D | $2.59 · 2026-03-16 to 2032-03-16 | 5,000 Common Stock | (F1) Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022. All unvested equity awards forfeited upon retirement. |